Prof. Martin Michaelis received his Ph.D. in 1998 and his Ph.D. in 2001 from Goethe-Universitat Frankfurt am Main,
Germany. Then, He worked as Postdoc and Later Deputy Group Leader in the research group of Prof. Jindrich Cinatl at the Institute of Medical Virology (Goethe-University, Frankfurt am Main, Germany) and the Dr. Petra Joh-Forschungshaus, a private research institute run by the Frankfurter Stiftung für krebskranke Kinder in Frankfurt am Main. In addition, he runs a joint wet/dry laboratory research group with Dr. Mark Wass. His most recent work has focused on COVID-19, where he has provided expert media commentary on vaccines and other treatments, variants and restrictions. His expertise on COVID-19 has seen him feature in a wide range of news outlets, including the Daily Express, the Daily Mail, BBC Radio Kent, the Daily Mirror and the Sunday Telegraph. His research interests include identification and investigation of drugs and their mechanisms of action; acquired resistance in cancer; virulence mechanisms and therapeutic targets in viruses; and meta-research investigating research practices in the life sciences.
